• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Neoleukin Therapeutics Inc (NQ: NLTX )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EST, Dec 18, 2023 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Neoleukin Therapeutics Inc

    < Previous 1 2 3 Next >
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Why Orchard Therapeutics Shares Are Trading Higher By Around 95%; Here Are 20 Stocks Moving Premarket
    Gainers 
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    Pre-market stock movers are rising and falling on Thursday as we check out all of the latest news worth knowing about this morning! 
    Via InvestorPlace
    Neoleukin Pauses Development Of NL-201, Cuts 40% Of Employee Strength
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Neoleukin Therapeutics To Merge With Neurogene: Creates Biotech Firm Focused On Genetic Medicines For Neurological Diseases
    Privately-held Neurogene Inc has agreed to merge with Neoleukin Therapeutics Inc (NASDAQ: NLTX) in  
    Via Benzinga
    US Stocks Turn Lower; S&P 500 Down 1%
    U.S. stocks turned lower toward the end of trading, with the Dow Jones dropping around 300 points on Thursday. The Dow traded down 0.88% to 32,510.83 while the NASDAQ fell 1.34% to 11,421.06. The S&P... 
    Via Benzinga
    Why JD.com Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Gainers 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    US Stocks Pare Gains; BJ's Wholesale Club Earnings Top Views
    U.S. stocks traded slightly higher midway through trading, with the Nasdaq Composite gaining 20 points on Thursday. The Dow traded up 0.02% to 32,804.33 while the NASDAQ rose 0.17% to 11,595.87. The... 
    Via Benzinga
    Neoleukin Therapeutics Seeks Strategic Alternatives, To Layoff More In Round 2 Within 6 Months
    Neoleukin Therapeutics Inc (NASDAQ: NLTX) has engaged SVB Securities to assist in reviewing strategic alternatives.  
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Why Cassava Sciences Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
    Gainers 
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    It's time for another breakdown of the biggest pre-market stock movers traders will want to know about on Thursday morning! 
    Via InvestorPlace
    Stocks That Hit 52-Week Lows On Wednesday
      On Wednesday, 70 companies set new 52-week lows. 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2022
    Upgrades 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    5 Analysts Have This to Say About Neoleukin Therapeutics
    Analysts have provided the following ratings for Neoleukin Therapeutics (NASDAQ:NLTX) within the last quarter: 
    Via Benzinga
    Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From Yesterday
    Gainers Satixfy Communications Ltd. (NYSE: SATX) shares gained 140.7% to settle at $31.80 on Tuesday. 
    Via Benzinga
    Pinterest To $23? Plus This Analyst Slashes PT On Neoleukin Therapeutics By More Than 90%
    Rosenblatt raised the price target on Pinterest, Inc. (NYSE: PINS) from $21 to $23. Rosenblatt analyst Barton Crockett maintained a Neutral rating on the stock. Pinterest shares rose 2% to $24.91 in... 
    Via Benzinga
    Intellia Therapeutics To Rally Around 143%? Plus Stifel Cuts PT On This Stock By 94%
      Chardan Capital boosted the price target on Intellia Therapeutics, Inc. (NASDAQ: NTLA) from $121 to $129. Intellia Therapeutics shares fell 3% to close at $53.30 on Monday. 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Gainers 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2022
    Upgrades 
    Via Benzinga
    HC Wainwright Cuts Price Target On This Stock By 73%, Also Check Out Other Major PT Changes Here
    Susquehanna cut the price target on Baidu, Inc. (NASDAQ: BIDU) from $200 to $195. Susquehanna analyst Shyam Patil maintained the stock with a Positive rating. Baidu shares rose 0.7% to $139.38 in... 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
      
    Via Benzinga
    Why Is Toast Trading Higher By 20%: Here Are 34 Stocks Moving Premarket
    Gainers Neptune Wellness Solutions Inc. (NASDAQ: NEPT) shares rose 66.9% to $2.37 in pre-market trading. Neptune Wellness Solutions recently announced voluntary delisting from Toronto Stock Exchange. 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
      
    Via Benzinga
    Recap: Neoleukin Therapeutics Q2 Earnings
      Neoleukin Therapeutics (NASDAQ:NLTX) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:05 PM. Here's what investors need to know about the announcement. 
    Via Benzinga
    Neoleukin Therapeutics Earnings Preview
      Neoleukin Therapeutics (NASDAQ:NLTX) is set to give its latest quarterly earnings report on Tuesday, 2022-08-09. Here's what investors need to know before the announcement. 
    Via Benzinga
    6 Penny Stocks With 1,000% Upside Potential
    Each of these penny stocks with 1,000% upside potential could rise 10X in the future for investors with a high risk tolerance. 
    Via InvestorPlace
    < Previous 1 2 3 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.